Ocular surface toxicity associated with topical interferon alpha-2b.
Aldave
Anthony J
AJ
Nguyen
Anne
A
D000287:Administration, Topical; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002278:Carcinoma in Situ / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003230:Conjunctival Neoplasms / Q000188:drug therapy*; D019573:Epithelium, Corneal / Q000187:drug effects*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D016896:Treatment Outcome; D014792:Visual Acuity
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins